>全球造血药物市场,按类别(贫血药物、造血生长因子药物、其他药物)、适应症(缺铁性贫血、巨幼细胞性贫血、造血生长因子疾病、其他药物)、给药途径(口服、肠胃外、其他药物)、最终用户(医院、家庭护理、专科中心、其他药物)、分销渠道(医院药房、网上药房、零售药房)划分——行业趋势和预测到 2029 年。
造血剂市场分析及规模
预计全球造血剂市场在预测期内将出现显著增长。造血剂市场有望通过提高血红蛋白水平和红细胞白细胞和血小板计数来改善血液的质量和数量。造血剂市场通常用于治疗贫血。疲惫和疲倦、头痛、皮肤干燥粗糙、不安腿综合症、神经认知功能障碍、血流动力学不稳定和皮肤发黄是造血障碍的主要症状。
Data Bridge Market Research 分析了 2022-2029 年预测期内全球造血剂市场的增长率。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
造血药物市场范围和细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制为 2014 - 2019) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
类别(贫血药物、造血生长因子药物、其他药物)、适应症(缺铁性贫血、巨幼细胞性贫血、造血生长因子疾病、其他药物)、给药途径(口服、肠胃外、其他药物)、最终用户(医院、家庭护理、专科中心、其他药物)、分销渠道(医院药房、网上药房、零售药房) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), PHARMACOSMOS A/S (Denmark), Akebia Therapeutics, Inc. (U.S.) |
Market Opportunities |
|
Market Definition
Hematopoiesis is the formation of blood in the body. It is the complex process of proliferation, differentiation and maturation of the cellular components that is erythrocytes, platelets and leucocytes from the bone marrow stem cells. The balanced interaction between the endogenously derived hematopoietic growth factor and exogenously supplied important nutrients such as hematinics regulates the hematopoiesis process.
Global Hematopoietic Agents Market Dynamics
Drivers
- Strategic Alliances
Vendors are concentrating on addressing the issues related with the high cost of research and development activities of therapeutic drugs by collaborating with pharmaceutical companies. They are also increasing their distribution networks through several strategic alliances with other vendors. As a result, developing and commercialization advanced therapies and drugs for lymphopenia is growing. This development is estimated to have a high impact on the market growth. This boost the market growth.
- Rise in Transplants
As per the studies by Worldwide Network for Blood and Marrow Transplantation (WBMT), it is projected that in 2019, nearly 1.5 million HSCTs were performed globally. Over the last two decades, hematopoietic stem cell transplant (HSCT) has seen fast expansion to become the standard of care for several patients with congenital or acquired disorders of the hematopoietic system or with chemo- radio- or, immuno- sensitive malignancies. Thus, this factor boost the market growth.
Opportunities
- Surge in usage in Hospitals
Hospitals and specialty clinics are the biggest consumer of the any type of lymphoma treatment market and it is rising because of the development of more and more hospitals. In addition to this, healthcare companies are also launching new and improved formulations of drugs for lowering the lymphopenia cases. Thus, this higher demand from hospitals for this type of therapeutics is creating opportunities for the market growth.
- Rising Lymphoma Cases
In 2020, as per the International Agency of Research on Cancer (IARC), on a global scale, out of every 100,000 individuals, 336,669 individuals were suffering from leukemia. 64,067 with Hodgkin lymphoma, and 399,610 with non-Hodgkin lymphoma. Hematopoietic stem cells have the capacity to produce more blood cells, such as red blood cells, white blood cells, and platelets. The global hematopoietic agents market is projected to grow based on these factors. This creates more opportunities in the market.
Restraints/Challenges
- Lack of Skilled Professionals
Lack of trained healthcare professionals who are unaware of knowledge of the treatment process could curb the growth of the global hematopoietic agents market over a forecast period.
- Side Effects of Hematopoietic Agents
There are various side effects that may hinder the growth of the market. Adverse effects such as anemia, hair loss, fatigue, and nausea cause the patient’s life difficulties. The diseased condition is severe and thus many of the patients require chemotherapy which can lead to side-effects such as sore mouth, loss of appetite, tiredness, infections and many such factors.
This global hematopoietic agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global hematopoietic agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Hematopoietic Agents Market Scope
The global hematopoietic agents market is segmented on the basis of class, indications, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Class
- Agents for Anemia
- Hematopoietic Growth Factors
- Others
Indications
- Iron Deficiency Anemia
- Megaloblastic Anemia
- Hematopoietic Growth Factors Disorders
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Hematopoietic Agents Market Regional Analysis/Insights
The global hematopoietic agents market is analyzed and market size insights and trends are provided by class, indications, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global hematopoietic agents market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
由于拥有该产品的关键制造基地、高额的研发和医疗保健支出以及熟练的专业人员,北美预计将拥有最高的市场增长。
由于政府宣传活动的加强、女性缺铁患病率的上升以及仿制药制造商的存在,亚太地区占据了市场主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球造血药物市场份额分析
全球造血剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球造血剂市场的关注有关。
全球造血剂市场的主要参与者包括:
- F. Hoffmann-La Roche Ltd.(瑞士)
- Mylan NV(美国)
- Teva Pharmaceutical Industries Ltd.(以色列)
- 赛诺菲(法国)
- 辉瑞公司(美国)
- 葛兰素史克公司 (英国)
- 诺华公司(瑞士)
- 拜耳公司(德国)
- 默克公司(美国)
- AbbVie Inc.(美国)
- 太阳制药工业有限公司 (印度)
- Aurobindo Pharma(印度)
- 鲁冰花(印度)
- Hikma Pharmaceuticals PLC(英国)
- PHARMACOSMOS A/S(丹麦)
- Akebia Therapeutics, Inc.(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.